Intellia Therapeutics Inc buy Cantor Fitzgerald
Start price
24.06.24
/
50%
€23.43
Target price
24.06.25
€60.53
Performance (%)
-10.88%
Price
22:26
€20.88
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -10.88%. This prediction currently runs until 24.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intellia Therapeutics Inc | -10.88% |
iShares Core DAX® | -0.079% |
iShares Nasdaq 100 | 0.247% |
iShares Nikkei 225® | 1.918% |
iShares S&P 500 | 0.146% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.97
18.06.24
18.06.24
€60.53
18.06.25
18.06.25
-9.10%
22:26
22:26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€21.64
04.06.24
04.06.24
€59.71
04.06.25
04.06.25
-3.51%
22:26
22:26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€34.13
13.09.23
13.09.23
€60.55
13.09.24
13.09.24
-38.82%
22:26
22:26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.09
29.08.23
29.08.23
€59.70
29.08.24
29.08.24
-40.50%
22:26
22:26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€37.03
10.08.23
10.08.23
€58.92
10.08.24
10.08.24
-43.61%
22:26
22:26